International Patent: TRICYCLIC BTK DEGRADATION AGENT AND USE THEREOF IN MEDICINE

GENEVA, June 26 -- HAISCO PHARMACEUTICAL GROUP CO., LTD. filed a patent application (CN2025/139901) for “TRICYCLIC BTK DEGRADATION AGENT AND USE THEREOF IN MEDICINE”. With publication no. WO/2026/119221, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 471/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....